$293 Million is the total value of ARMISTICE CAPITAL, LLC's 39 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SPDR S&P 500 ETF TRput | $19,159,000 | – | 100,000 | +100.0% | 6.54% | – | |
| GSK | New | GLAXOSMITHKLINE PLCcall | $15,380,000 | – | 400,000 | +100.0% | 5.25% | – |
| PTX | New | PERNIX THERAPEUTICS HOLDINGS | $15,168,000 | – | 4,800,000 | +100.0% | 5.18% | – |
| THRX | New | THERAVANCE BIOPHARMA INC | $14,727,000 | – | 1,341,000 | +100.0% | 5.03% | – |
| FRPT | New | FRESHPET INC | $11,760,000 | – | 1,120,000 | +100.0% | 4.02% | – |
| BDBD | New | BOULDER BRANDS INC | $10,369,000 | – | 1,266,000 | +100.0% | 3.54% | – |
| PBY | New | PEP BOYS MANNY MOE & JACK | $10,240,000 | – | 840,000 | +100.0% | 3.50% | – |
| GMCR | New | KEURIG GREEN MTN INC | $8,030,000 | – | 154,000 | +100.0% | 2.74% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $7,787,000 | – | 506,000 | +100.0% | 2.66% | – |
| SPNC | New | SPECTRANETICS CORP | $7,357,000 | – | 624,000 | +100.0% | 2.51% | – |
| LVS | New | LAS VEGAS SANDS CORP | $7,214,000 | – | 190,000 | +100.0% | 2.46% | – |
| DECK | New | DECKERS OUTDOOR CORP | $6,967,000 | – | 120,000 | +100.0% | 2.38% | – |
| DFRG | New | DEL FRISCOS RESTAURANT GROUP | $5,862,000 | – | 422,000 | +100.0% | 2.00% | – |
| VNCE | New | VINCE HOLDING CORP | $5,282,000 | – | 1,540,000 | +100.0% | 1.80% | – |
| ARCO | New | ARCOS DORADOS HOLDINGS INC | $3,808,000 | – | 1,400,000 | +100.0% | 1.30% | – |
| SNTA | New | SYNTA PHARMACEUTICALS CORP | $3,480,000 | – | 2,000,000 | +100.0% | 1.19% | – |
| MDGS | New | MEDIGUS LTDsponsored adr | $2,696,000 | – | 601,700 | +100.0% | 0.92% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $1,622,000 | – | 836,000 | +100.0% | 0.55% | – |
| CPHRF | New | CIPHER PHARMACEUTICALS INC | $1,115,000 | – | 300,000 | +100.0% | 0.38% | – |
| APHB | New | AMPLIPHI BIOSCIENCES CORP | $371,000 | – | 93,850 | +100.0% | 0.13% | – |
| TENX | New | TENAX THERAPEUTICS INC | $266,000 | – | 88,739 | +100.0% | 0.09% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.